DMF5 cell therapy

DMF5 TCR-engineered T cells · National Cancer Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DMF5 cell therapy, covering 2012-06-07 to 2012-06-07. Get the full timeline:

Most recent: Clinical Trial Update: Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma [Phase 1, Phase 2]